Literature DB >> 565506

ABO hemolytic disease of the newborn: evaluation of management and identification of racial and antigenic factors.

K J Peevy, H J Wiseman.   

Abstract

Data from 16,320 deliveries from two time periods were examined to compare the incidence of positive direct Coombs' tests and the number of exchange transfusions performed, using different methods of screening and treatment in each time period. Early routine screening revealed an eightfold increase in the number of Coombs-positive infants, while the combined effect of instituting early screening and the change from white light to special blue light phototherapy greatly diminihsed the number of exchange transfusions. In addition, data concerning racial and blood antigen factors in ABO hemolytic disease of the newborn (HDN) are compared, showing an increase in incidence but no increase in severity for black infants and infants with blood type B. Also, use of cord blood parameters in management of ABO HDN is discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 565506     DOI: 10.1542/peds.61.3.475

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  4 in total

1.  Hemolysis and hyperbilirubinemia in antiglobulin positive, direct ABO blood group heterospecific neonates.

Authors:  Michael Kaplan; Cathy Hammerman; Hendrik J Vreman; Ronald J Wong; David K Stevenson
Journal:  J Pediatr       Date:  2010-07-02       Impact factor: 4.406

2.  Does ABO incompatibility matter?

Authors:  M W Quinn; A M Weindling; D C Davidson
Journal:  Arch Dis Child       Date:  1988-10       Impact factor: 3.791

3.  Study of 25 cases of exchange transfusion by reconstituted blood in hemolytic disease of newborn.

Authors:  D C Sharma; Sunita Rai; Aakash Mehra; M M Kaur; Satya Sao; Ajay Gaur; Rahul Sapra
Journal:  Asian J Transfus Sci       Date:  2007-07

4.  Estimating the Risk of ABO Hemolytic Disease of the Newborn in Lagos.

Authors:  Alani Sulaimon Akanmu; Olufemi Abiola Oyedeji; Titilope Adenike Adeyemo; Ann Abiola Ogbenna
Journal:  J Blood Transfus       Date:  2015-09-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.